Ventavis is a Respiratory (inhalation) Solution in the Human Prescription Drug category. It is labeled and distributed by Actelion Pharmaceuticals Us, Inc.. The primary component is Iloprost.
| Product ID | 66215-303_0b1c1ba9-8e91-4721-9a6d-7795ccbad767 |
| NDC | 66215-303 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Ventavis |
| Generic Name | Iloprost |
| Dosage Form | Solution |
| Route of Administration | RESPIRATORY (INHALATION) |
| Marketing Start Date | 2009-08-24 |
| Marketing Category | NDA / NDA |
| Application Number | NDA021779 |
| Labeler Name | Actelion Pharmaceuticals US, Inc. |
| Substance Name | ILOPROST |
| Active Ingredient Strength | 0 mg/mL |
| Pharm Classes | Prostacycline [EPC],Prostaglandins I [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2009-08-24 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA021779 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2009-08-24 |
| Marketing Category | NDA |
| Application Number | NDA021779 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2009-08-24 |
| Ingredient | Strength |
|---|---|
| ILOPROST | .02 mg/mL |
| SPL SET ID: | d3bebc1c-f032-402a-bbc9-aff024276ed1 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 66215-302 | Ventavis | iloprost |
| 66215-303 | Ventavis | iloprost |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() VENTAVIS 85254212 4028843 Live/Registered |
BAYER INTELLECTUAL PROPERTY GMBH 2011-03-01 |
![]() VENTAVIS 76209350 2926127 Dead/Cancelled |
BAYER SCHERING PHARMA AKTIENGESELLSCHAFT 2001-02-13 |